Stephenson Harwood advises Apposite Capital on Emblation investment

Law firm Stephenson Harwood LLP has advised healthcare investor Apposite Capital on its investment in medical device company, Emblation.

Established in 2007, Emblation designs, manufactures and commercialises next generation microwave-based solutions for a range of skin conditions. Its products, which are currently sold in the UK, North America and Australia, have been used in more than 130,000 treatments. This investment will support Emblation’s international growth, as well as enable it to expand its technology platform.

The Stephenson Harwood team was led by partner Richard Coleman, who was supported by senior associate Emily Davies.